HF
DFTX

HRT Financial’s Definium Therapeutics DFTX Stock Holding History

HRT Financial’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.68M Buy
89,141
+62,859
+239% +$1.07M ﹤0.01% 1729
2025
Q4 		$351K Sell
26,282
-31,283
-54% -$387K ﹤0.01% 2298
2025
Q3 		$678K Buy
+57,565
New +$537K ﹤0.01% 1716
2025
Q2 		– Sell
-16,703
Closed -$97K – 3211
2025
Q1 		$97K Buy
+16,703
New +$120K ﹤0.01% 2152
2024
Q2 		– Sell
-207,253
Closed -$1.95M – 2753
2024
Q1 		$1.95M Buy
+207,253
New +$1.18M 0.01% 577
2022
Q3 		– Sell
-11,589
Closed -$111K – 3243
2022
Q2 		$111K Buy
11,589
+10,782
+1,336% +$136K ﹤0.01% 2412
2022
Q1 		$13K Sell
807
-376
-32% -$6.52K ﹤0.01% 2878
2021
Q4 		$24K Buy
+1,183
New +$37.8K ﹤0.01% 2926

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HRT Financial's DFTX Position: Q1 2026 in Review

HRT Financial increased its Definium Therapeutics (DFTX) stake by 239% in Q1 2026, buying an estimated $1.07M and bringing the position to 89,141 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1729.

HRT Financial first reported a position in DFTX in Q4 2021 and has held it in 8 quarters since. The position peaked at $1.95M in Q1 2024. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • HRT Financial held 89,141 shares of Definium Therapeutics worth $1.68M as of Q1 2026.
  • HRT Financial bought 62,859 Definium Therapeutics shares in Q1 2026, an estimated $1.07M.
  • Definium Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #1729 holding.
  • HRT Financial first reported a position in Definium Therapeutics in Q4 2021 and has held it in 8 quarters since.
  • HRT Financial's Definium Therapeutics position peaked at $1.95M in Q1 2024.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.